May 02, 2025

Psychotherapy, Family Tied to Better Outcomes

In a large meta-analysis, researchers identified the most effective components of collaborative care for treating depression in primary care.

Conexiant

May 01, 2025

FDA Approves Intranasal DHE for Acute Migraine Relief

The FDA has approved Atzumi for the acute treatment of migraine with or without aura in adults.

Conexiant

April 29, 2025

Foley Catheter Management: New Best Practices, Pitfalls

Foley catheter use is associated with a wide range of complications, from infections to urethral erosion.

Conexiant

April 25, 2025

WHI Funding Restored After Uproar

"We are now working to fully restore funding to these essential research efforts."

Conexiant

April 24, 2025

FDA Warns of Topical Finasteride Risks

The FDA has issued a safety alert on compounded topical finasteride products, citing adverse events and emphasizing the lack of regulatory approval or safety evaluation.

Conexiant

April 21, 2025

New Findings Show No Difference in IGE Treatment Strategies

A study found no statistically significant differences in treatment failure rates between substitution monotherapy and add-on therapy for women with idiopathic generalized epilepsy, indicating both options are viable.

Conexiant

April 16, 2025

CONSORT 2025: Setting New Standards for Clinical Trial Reporting

"Readers should not have to infer what was probably done; they should be told explicitly." This principle drives the comprehensive CONSORT 2025 update, with its 7 new checklist items aimed at improving clinical trial transparency.

Conexiant

April 14, 2025

Postpartum Contraceptives Linked to Depression Risk

Researchers study found that initiating hormonal contraceptives postpartum was associated with an increased risk of depression within 12 months after childbirth.

Conexiant

April 11, 2025

New Meta-Analysis Updates Vitamin D Evidence

This meta-analysis of 46 randomized trials found no statistically significant effect of vitamin D supplementation on acute respiratory infection prevention overall or across subgroups.

Conexiant